Literature DB >> 14611815

Role of Ets/Id proteins for telomerase regulation in human cancer cells.

Xiaodong Xiao1, Meropi Athanasiou, Igor A Sidorov, Izumi Horikawa, Gina Cremona, Donald Blair, J Carl Barret, Dimiter S Dimitrov.   

Abstract

Most human cancers express telomerase but its activity is highly variable and regulated by complex mechanisms. Recently, we have proposed that Ets proteins may be important for regulation of telomerase activity in leukemic cells. Here we provide further evidence for the role of Ets family members and related Id proteins in telomerase regulation and characterize the underlying molecular mechanisms. By using PCR-based and gel shift assays we demonstrated specific binding to a core hTERT promoter of Ets2, Fli1, Id2, c-Myc, Mad1, and Sp1 in lysates from subclones of U937 cells. Further analysis of binding of purified proteins and various mutants of the hTERT promoter suggested the existence of a trimolecular Ets-Id2-DNA complex, and Ets inhibitory activity mediated by c-Myc and the Ets binding site on the core hTERT promoter at -293 bp from the transcription initiation site as well as a positive Ets regulatory effect mediate through another Ets binding site at -36 bp. This analysis provided evidence for the existence of negative and positive Ets regulatory site and suggested a complex interplay between Ets/Id family members and c-Myc that may be an important determinant of the diversity of telomerase activity in leukemia and other cancers.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14611815     DOI: 10.1016/s0014-4800(03)00092-3

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  14 in total

1.  Epidermal growth factor activates telomerase activity by direct binding of Ets-2 to hTERT promoter in lung cancer cells.

Authors:  Chung-Ping Hsu; Li-Wen Lee; Sheau-Chung Tang; I-Lun Hsin; Yu-Wen Lin; Jiunn-Liang Ko
Journal:  Tumour Biol       Date:  2015-02-14

2.  Ets2 maintains hTERT gene expression and breast cancer cell proliferation by interacting with c-Myc.

Authors:  Dakang Xu; Julie Dwyer; He Li; Wei Duan; Jun-Ping Liu
Journal:  J Biol Chem       Date:  2008-06-27       Impact factor: 5.157

3.  Transcriptional activation of hTERT, the human telomerase reverse transcriptase, by nuclear factor of activated T cells.

Authors:  Amel Chebel; Jean-Pierre Rouault; Iwona Urbanowicz; Lucile Baseggio; Wei-Wen Chien; Gilles Salles; Martine Ffrench
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

Review 4.  Understanding TERT Promoter Mutations: A Common Path to Immortality.

Authors:  Robert J A Bell; H Tomas Rube; Ana Xavier-Magalhães; Bruno M Costa; Andrew Mancini; Jun S Song; Joseph F Costello
Journal:  Mol Cancer Res       Date:  2016-03-03       Impact factor: 5.852

5.  The transcription factor Fli-1 modulates marginal zone and follicular B cell development in mice.

Authors:  Xian K Zhang; Omar Moussa; Amanda LaRue; Sarah Bradshaw; Ivan Molano; Demetri D Spyropoulos; Gary S Gilkeson; Dennis K Watson
Journal:  J Immunol       Date:  2008-08-01       Impact factor: 5.422

6.  Regulation of hTERT transcription: a target of cellular and viral mechanisms for immortalization and carcinogenesis.

Authors:  Izumi Horikawa; Eriko Michishita; J Carl Barrett
Journal:  Cytotechnology       Date:  2004-06       Impact factor: 2.058

7.  Wilms' tumour 1 can suppress hTERT gene expression and telomerase activity in clear cell renal cell carcinoma via multiple pathways.

Authors:  R T Sitaram; S Degerman; B Ljungberg; E Andersson; Y Oji; H Sugiyama; G Roos; A Li
Journal:  Br J Cancer       Date:  2010-09-14       Impact factor: 7.640

8.  The regulation of telomerase in oncogenesis.

Authors:  D A Skvortzov; M P Rubzova; M E Zvereva; F L Kiselev; O A Donzova
Journal:  Acta Naturae       Date:  2009-04       Impact factor: 1.845

9.  Inhibitor of differentiation 4 (Id4) is a potential tumor suppressor in prostate cancer.

Authors:  Jason P W Carey; Ananthi J Asirvatham; Oliver Galm; Tandeih A Ghogomu; Jaideep Chaudhary
Journal:  BMC Cancer       Date:  2009-06-07       Impact factor: 4.430

10.  Epigenetic inactivation of inhibitor of differentiation 4 (Id4) correlates with prostate cancer.

Authors:  Pankaj Sharma; Swathi Chinaranagari; Divya Patel; Jason Carey; Jaideep Chaudhary
Journal:  Cancer Med       Date:  2012-08-02       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.